Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Perna, Lucia ^a   Cozzarini, Cesare ^a   Maggiulli, Eleonora ^a   Fellin, Gianni ^b   Rancati, Tiziana ^c   Valdagni, Riccardo ^c   Vavassori, Vittorio ^d   Villa, Sergio ^c   Fiorino, Claudio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Humanitas Gavazzeni Hospital   (Italy)

Author keywords

Inter observer variability; Penile bulb, prostate cancer

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PENIS; PROSTATE CARCINOMA; RADIATION DOSE; TREATMENT PLANNING; WILCOXON SIGNED RANKS TEST; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; METHODOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; RADIOGRAPHY; RADIOMETRY; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING;

COMPUTER SIMULATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; PENIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053174917     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-123     Document Type: Article

References (48)

1. Incrocci L, Slob AK, Levenday PC. Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys 2002, 52:681-693. 10.1016/S0360-3016(01)02727-4, 11849790.
2. Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: what do we know?. Oncol Hematol 2006, 57:165-173.
3. Incrocci L. Changes in sexual function after treatment of male cancer. JMHG 2005, 2:236-243.
4. Incrocci L. Erectile dysfunction and radiation therapy for prostate cancer. Sexologies 2006, 15:116-120.
5. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54:1063-1068. 10.1016/S0360-3016(02)03030-4, 12419432.
6. Roach M, Chinn DM, Holland J, et al. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996, 35:869-874. 10.1016/0360-3016(96)00206-4, 8751394.
7. Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996, 54:124-129.
8. Nguyen L, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998, 51:991-997. 10.1016/S0090-4295(98)00028-4, 9609638.
9. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with threedimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998, 41:491-500. 10.1016/S0360-3016(98)00091-1, 9635694.
10. Borghede G, Hedelin H. Radiotherapy of localized prostate cancer. Analysis of late treatment complications. A prospective study. Radiother Oncol 1997, 43:139-146. 10.1016/S0167-8140(96)01871-3, 9192958.
11. Turner SL, Adams K, Bull CA, et al. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology 1999, 54:124-129. 10.1016/S0090-4295(99)00032-1, 10414738.
12. Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000, 163:460-463. 10.1016/S0022-5347(05)67900-1, 10647654.
13. Goldstein I, Feldman MI, Deckers PJ, et al. Radiation-associated impotence. A clinical study of its mechanism. Jama 1984, 251:903-910. 10.1001/jama.251.7.903, 6694291.
14. Siegel T, Moul JW, Spevak M, et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001, 165:1582-1592.
15. Pickett B, Fisch BM, Weinberg V, et al. Dose to the bulb of the penis is associated with the risk of impotence following radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45:263.
16. Merrick GS, Butler WM, Wallner KE, et al. The importance of radiation doses to the penile bulb vs. crura in the development of post brachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002, 54:1055-1062. 10.1016/S0360-3016(02)03031-6, 12419431.
17. Kitelet RA, Lee WR, deGuzman AF, et al. Radiation dose to neurovascula bundles of penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 2002, 1:90-94. 10.1016/S1538-4721(02)00018-1, 15062176.
18. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 1998, 40:129-133. 10.1016/S0360-3016(97)00554-3, 9422568.
19. Mittal B. A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence. Int J Radiat Oncol Biol Phys 1985, 11:11-21.
20. Mulhall JP, Yonover P, Sethi A, et al. Radiation exposure to the corporeal bodies during 3 dimensional conformal radiotherapy for prostate cancer. J Urol 2002, 167:539-542. 10.1016/S0022-5347(01)69081-5, 11792914.
21. Mulhall JP, Yonover P. Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer [Letter]. Urology 2002, 58:828.
22. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54:1063-1068. 10.1016/S0360-3016(02)03030-4, 12419432.
23. Fisch BM, Pickett B, Weinberg V, et al. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 2001, 57:955-959. 10.1016/S0090-4295(01)00940-2, 11337302.
24. Roach M, Winter K, Michalski JM, et al. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 2004, 60:1351-1356. 10.1016/j.ijrobp.2004.05.026, 15590164.
25. Mangar SA, Sydes MR, Tucker HL, et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer. Radiother Oncol 2006, 80:355-362. 10.1016/j.radonc.2006.07.037, 16949694.
26. Wernicke AG, Valicenti R, DiEva K, et al. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after threedimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004, 60:1357-1363. 10.1016/j.ijrobp.2004.05.030, 15590165.
27. Selek U, Cheng R, Lii M, et al. Erectile dysfunction and radiation dose to the penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys 2004, 59:1039-1046. 10.1016/j.ijrobp.2003.12.028, 15234037.
28. Sethi A, Mohideen N, Leybovich L, Mulhall J. Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 55:970-978. 10.1016/S0360-3016(02)04164-0, 12605975.
29. Kao J, Turian J, Meyers A, Hamilton RJ, Smith B, Vijayakumar S, et al. Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer. Br J Radiol 2004, 77:129-136. 10.1259/bjr/37893924, 15010385.
30. Young CD, Speight JL, Akazawa PF, Pickett B, Verhey LJ, Roach M. Improved conformal coverage of the prostate with an IMRT potency-sparing technique. Int J Radiat Oncol Biol Phys 2000, 48:351.
31. Perna L, Fiorino C, Cozzarini C, et al. Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy. Radiother Oncol 2009, 93:57-63. 10.1016/j.radonc.2009.04.004, 19410316.
32. Van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007, 84:107-113. 10.1016/j.radonc.2007.07.018, 17707936.
33. Fiorino C, Valdagni R, Rancati T, Sanguineti G. Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol 2009, 93:153-167. 10.1016/j.radonc.2009.08.004, 19765845.
34. Roach M, Nam J, Gagliardi G, et al. Radiation dose-volume effects and the penile bulb. Int J Radiat Oncol Biol Phys 2010, 76:S130-S134. 10.1016/j.ijrobp.2009.04.094, 20171507.
35. Debois M, Oyen N, Maes F, et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45:857-865. 10.1016/S0360-3016(99)00288-6, 10571190.
36. Rasch C, Barillot I, Remeijer P, et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999, 43:57-66. 10.1016/S0360-3016(98)00351-4, 9989514.
37. Milosevic M, Voruganti S, Blend R, et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and uretrography. Radiother Oncol 1998, 47:277-284. 10.1016/S0167-8140(97)00232-6, 9681891.
38. Algan O, Hanks GE, Shaer AH. Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys 1995, 33:925. 10.1016/0360-3016(95)00226-4, 7591904.
39. Roach M. Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency sparing radiotherapy?. Int J Radiat Oncol Biol Phys 2005, 61:1-2. 10.1016/j.ijrobp.2004.05.038, 15629584.
40. Pickett B, Kurhanewicz J, Fein B, Coakley F, Shinohara K, Roach M. Use of magnetic resonance imaging and spectroscopy in the evaluation of external beam radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 2:S163.
41. Rasch C, Remeijer P, Barillot I, van Herk M, Lebesque JV. Observer and imaging modality (CT, MRI) related definition of the prostate. Int J Radiat Oncol Biol Phys 1997, 2:S288.
42. Malone S, Crook J, Perry G, Broeders M, Salhani D, Gerig L, et al. Effects of uretrography on prostate position: considerations for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 1997, 2:S288.
43. Akazawa PF, Roach M, Malfatti C, Hrieak H. A comparison of the prostate volume defined by magnetic resonance imaging and computed tomographic (CT) scans during treatment for prostate cancer. Int J Radiat Oncol Biol Phys 1995, 152.
44. McLaughlin P, Narayana V, Meirovitz A, et al. Vessel-sparing prostate radiotherapy dose limitation to critical erectile vascular structures (internal pudental artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 2005, 61:20-31. 10.1016/j.ijrobp.2004.04.070, 15629590.
45. Wallner KE, Merrick GS, Benson ML, et al. Penile bulb imaging. Int J Radiat Oncol Biol Phys 2002, 53:928-933. 10.1016/S0360-3016(02)02805-5, 12095559.
46. Fiorino C, Reni M, Bolognesi A, et al. Intra and inter-observer variability in contouring prostate and seminal vesicles: implication for conformal treatment planning. Radiother Oncol 1998, 47:285-292. 10.1016/S0167-8140(98)00021-8, 9681892.
47. Fiorino C, Vavassori V, Sanguineti G, et al. Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability. Radiother and Oncol 2002, 63:249-255.
48. Foppiano F, Fiorino C, Frezza G, et al. The impact of contouring uncertainty on rectal 3d dose-volume data: results of a dummy run in a multicenter trial (airopros01-02). Int J Radiat Oncol Biol Phys 2003, 57:573-579. 10.1016/S0360-3016(03)00659-X, 12957271.